Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Update on therapeutic options for multiple sclerosis.
Studying the Effects of Semaphorins on Oligodendrocyte Lineage Cells.
Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Myelin-specific T helper 17 cells promote adult hippocampal neurogenesis through indirect mechanisms.
Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review.
[Neuromyelitis optica with high aquaporin-4 expression and positive serum aquaporin-4 autoantibodies].
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.
CMTX Disorder and CamKinase.
I kappa B kinase 2/beta deficiency controls expansion of autoreactive T cells and suppresses experimental autoimmune encephalomyelitis.
Ultrasonic Elastography Evaluation in Optic Neuritis.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.
Rehabilitation in Multiple Sclerosis: a Systematic Review of Systematic Reviews.
N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses.
Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.
Pediatric multiple sclerosis: Clinical features and outcome.
MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Role of Pulmonary Evaluation in Diagnosis of Neurosarcoidosis.
Splenic Marginal Zone Lymphoma: An indolent malignancy leading to the development of neurolymphomatosis.
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.
Clinical importance of F-waves as a prognostic factor in Guillain-Barré syndrome in children.
Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
Radiosurgery for Secondary Trigeminal Neuralgia: Revisiting the Treatment Paradigm.
Pages
« first
‹ previous
…
687
688
689
690
691
692
693
694
695
…
next ›
last »